Table 2. Summary of reported PA cases in breast cancer treated with GnRH agonist.

Study	Age/sex	Drug (dose, mg)	Interval to PA	FSH, LH (mIU/mL)	Surgical treatment	MR finding
Voica et al. [8]	53/F	Leuprolide (11.25)	4 days	NA	Transsphenoidal surgery	Macroadenoma, 1.5 cm (description only)
Present case	52/F	Leuprolide (3.75)	20 days	3.9, 0.4	Transsphenoidal surgery	PA with aseptic meningitis

PA, pituitary apoplexy; GnRH, gonadotropin-releasing hormone; FSH, follicle-stimulating hormone; LH, luteinising hormone; F, female; NA, not available